Showing results (2141-2150 of 2,589) with videos related to
Sort By:
Pageof 259
Molecular Oncology|May 18, 2021
Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1Palanivel Kandasamy, Inti Zlobec, Damian T Nydegger, et al.Molecular Oncology|May 16, 2020
Variability of EGFR exon 20 insertions in 24 468 Chinese lung cancer patients and their divergent responses to EGFR inhibitorsYanRu Qin, Hong Jian, Xiaoling Tong, et al.Molecular Oncology|June 15, 2020
Image guidance in radiation therapy for better cure of cancerVincent Grégoire, Matthias Guckenberger, Karin Haustermans, et al.Molecular Oncology|May 7, 2021
CDX2 expression in the hematopoietic lineage promotes leukemogenesis via TGFβ inhibitionAva Galland, Victor Gourain, Karima Habbas, et al.Molecular Oncology|June 9, 2015
An integrated genomic analysis of papillary renal cell carcinoma type 1 uncovers the role of focal adhesion and extracellular matrix pathwaysSamantha Jane Wala, Jason Raj Karamchandani, Rola Saleeb, et al.Molecular Oncology|May 21, 2015
Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genesIda Johansson, Martin Lauss, Karolina Holm, et al.Molecular Oncology|May 9, 2015
Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myelomaFelix Oden, Stephen F Marino, Janko Brand, et al.Molecular Oncology|June 9, 2020
FGFR1 clustering with engineered tetravalent antibody improves the efficiency and modifies the mechanism of receptor internalizationMarta Pozniak, Aleksandra Sokolowska-Wedzina, Kamil Jastrzebski, et al.Molecular Oncology|May 2, 2020
Estrogen receptor α promotes lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathwaysMiao He, Weiwei Yu, Chawnshang Chang, et al.Molecular Oncology|June 13, 2020
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapyTimothy V Pham, Amélie Boichard, Aaron Goodman, et al.Pageof 259